Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
暂无分享，去创建一个
S. Adams | L. Chiriboga | P. Ott | A. Pavlick | J. Goldberg | S. Gnjatic | A. Jungbluth | N. Bhardwaj | F. Darvishian | J. Vasilakos | Meredith R. Spadaccia | J. Mandeli | R. Sabado | L. Pan | R. Venhaus | J. Escalon | C. Cruz | F. Hasan | R. Holman | I. Vengco | Caroline Muren | C. Escano | E. Yepes | D. Sharpe | Linda Rolnitzsky | Isabelita Vengco